Showing results (1-10 of 390) with videos related to
Sort By:
Pageof 39
Clinical and Experimental Immunology|December 2, 2008
Complement in multiple sclerosis: its role in disease and potential as a biomarkerG Ingram, S Hakobyan, N P Robertson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Systemic complement profiling in multiple sclerosis as a biomarker of disease stateG Ingram, S Hakobyan, C L Hirst, et al.European Journal of Neurology|May 21, 2010
Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activityG Ingram, J J Bugert, S Loveless, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2008
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysisC Hirst, G Ingram, R Swingler, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Increasing prevalence and incidence of multiple sclerosis in South East WalesC Hirst, G Ingram, T Pickersgill, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2011
Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosisM Cossburn, G Ingram, C Hirst, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Validity of patient-derived disability and clinical data in multiple sclerosisG Ingram, E Colley, Y Ben-Shlomo, et al.Immunobiology|August 20, 2011
Variation in complement component C1 inhibitor in age-related macular degenerationJ Gibson, S Hakobyan, A J Cree, et al.Differentiation; Research in Biological Diversity|January 1, 1979
Incorporation of 35S-sulfate into yolk platelets of Xenopus laevis embryos. A study using electron microscope autoradiographyN P RobertsonComplement and Inflammation|January 1, 1989
Mechanisms of tissue damage by the membrane attack complex of complementB P MorganPageof 39